Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

These factors collectively contribute to the decision to maintain a Hold rating, reflecting a cautious stance amidst mixed signals in the company ... solutions for patients with obstructive sleep ...

New research suggests that cheese may help reduce sleep apnea risk, but that doesn't mean cheese is a sleep aid ...

A study reveals sleep apnea can cause brain damage, increasing risks of aging and dementia, particularly in Hispanic seniors.

After one month, the study participants had their sleep assessed according to the Pittsburgh Sleep Quality Index. Those who ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

The Apple Watch is a great smartwatch, but it is not the end-all, be-all. If you prefer another interface, check out these ...

Postmenopausal sleep issues contribute to a sharp decline in sleep quality among older women, beginning at approximately 51 ...

A recent study has found a surprising connection between sleep-related breathing problems and changes in the brain. Published ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

She says her experience navigating a mixed identity in Hollywood has been both challenging and illuminating. “Every job I’ve booked has come with questions about my percentages — how Mexican ...